Isoflavone Intake is Associated With Decreased Chronic Obstructive Pulmonary Disease Morbidity

Key Points

• The study aims to explore the association between isoflavone intake and respiratory morbidity in COPD patients.
• Analyzed isoflavone intake levels among individuals with COPD.
• Assessed respiratory morbidity and platelet activation levels.
• Performed statistical analysis to establish associations.
• Higher isoflavone intake correlates with lower respiratory morbidity.
• Reduced platelet activation is observed with increased isoflavone consumption.